- Home
- latamerica
- Equipment
Refine by
Locations
- Latin America
- Antigua & Barbuda
- Argentina
- Aruba
- Bahamas
- Barbados
- Belize
- Bolivia
- Brazil
- Cayman Islands
- Chile
- Colombia
- Costa Rica
- Dominica
- Dominican Republic
- Ecuador
- El Salvador
- Grenada
- Guatemala
- Guyana
- Haiti
- Honduras
- Jamaica
- Mexico
- Netherlands Antilles
- Nicaragua
- Panama
- Paraguay
- Peru
- Puerto Rico
- St. Kitts & Nevis
- St. Lucia
- St. Vincent & The Grenadines
- Suriname
- Trinidad
- Uruguay
- Venezuela
Applications
- Liposomes - Hollow Nanospheres for Gene Therapy
- Liposomes - Hollow Nanospheres for Cancer Therapy
- Liposomes - Hollow Nanospheres for Ocular Drug Delivery
- Liposomes - Hollow Nanospheres for Brain Drug Delivery
- Liposomes - Hollow Nanospheres for Vaccines
- Liposomes - Hollow Nanospheres for Immunomodulating Response
- Liposomes - Hollow Nanospheres for Tissue Engineering
- Exosomes - Extracellular Vesicles for Validation and Quality Control
- Exosomes - Extracellular Vesicles for Cancer Treatment
- Exosomes - Extracellular Vesicles for Immunomodulating Response
- Exosomes - Extracellular Vesicles for Molecular Therapy
- Exosomes - Extracellular Vesicles for Brain Drug Delivery
- Exosomes - Extracellular Vesicles for Ocular Drug Delivery
Nanovex Medical Equipment & Supplies In In Latin America
2 equipment items found
Manufactured by:Nanovex Biotechnologies based inLlanera, SPAIN
Liposomes are hollow nanospheres made of a double lipidic layer that enclose an aqueous core. They are similar to micelles besides the size and the number of lipidic ...
Manufactured by:Nanovex Biotechnologies based inLlanera, SPAIN
Exosomes are extracellular vesicles of natural origin that are produced by all cell types in the range of 40 to 160 nm. They have a key role in cell-to-cell communication and have been proved to be powerful tools in diagnosis and therapeutics. Their basic structure is very similar to liposomes, consisting of double lipid which is a slice of cell membrane and an aqueous based core which will be a ...
